Document Detail


The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks.
MedLine Citation:
PMID:  10843028     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine if a second intramuscular injection of ceftriaxone was necessary in febrile infants who meet low-risk criteria for outpatient therapy. SETTING: Children's Hospital Emergency Department. PATIENTS: Febrile infants 4-8 weeks of age. METHODS: Outpatient treatment criteria included non-toxic appearance, no identifiable source for infection on physical examination, CSF WBC > or = 10/mm3, peripheral WBC < or = 15,000/mm3, normal UA, and normal chest radiograph study, if obtained. Additional requirements included a reliable caretaker and re-evaluation in 24 hours. Infants who met these criteria received intramuscular ceftriaxone 50 mg/kg with instructions to follow-up in 24 hours. At the follow-up visit, infants with no identifiable source for infection and negative cultures received a second dose of intramuscular ceftriaxone and were discharged. Cultures were read at 48 hours and at the conclusion of the study. Medical records were reviewed to identify delayed complications. RESULTS: 172 infants were enrolled. The mean age was 45 days. All CBC, UA, CSF analyses were normal. Chest radiographs were obtained in 56 (30%) infants; all were normal. One (.05%) patient was admitted at the follow-up visit. The mean time to follow-up was 25 hours. Two positive cultures were identified at the re-evaluation visit; one blood culture grew Salmonella and a urine culture grew E. coli. The CSF cultures were all negative at follow-up and remained negative. CONCLUSION: Febrile infants 4-8 weeks of age who meet outpatient therapy criteria and have negative cultures and no identifiable source for infection at 24 hours may not require the second dose of intramuscular ceftriaxone.
Authors:
S E Allen; C M Walsh-Kelly; H H Hennes
Related Documents :
20461528 - Hospitalization of newborns and young infants for chickenpox in france.
18264888 - Endoscope disinfection and its pitfalls--requirement for retrograde surveillance cultures.
10359408 - Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal t...
6249068 - Generalized cytomegalic inclusion disease in neonates and infants.
23590958 - Transient hypothyroidism in premature infants after short-term topical iodine exposure:...
619188 - Monitoring occlusion and accidental extubation of tracheostomy tubes in children.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  WMJ : official publication of the State Medical Society of Wisconsin     Volume:  99     ISSN:  1098-1861     ISO Abbreviation:  WMJ     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-09-05     Completed Date:  2000-09-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9716054     Medline TA:  WMJ     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  60-2     Citation Subset:  IM    
Affiliation:
Emergency Medicine Section, Cincinnati Children's Hospital, OH, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ambulatory Care
Ceftriaxone / administration & dosage*,  therapeutic use
Cephalosporins / administration & dosage*,  therapeutic use
Drug Administration Schedule
Fever / drug therapy*
Humans
Infant
Infant, Newborn
Injections, Intramuscular
Patient Care Management
Prospective Studies
Chemical
Reg. No./Substance:
0/Cephalosporins; 73384-59-5/Ceftriaxone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Benefits of breastfeeding: a review for physicians.
Next Document:  Trends in smoking during pregnancy, Wisconsin 1990 to 1996.